Search for: "J. Johnson " Results 301 - 320 of 4,303
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2013, 6:15 pm
Three years later, J & J recalled approximately 93,000 artificial ASR hip implants. [read post]
20 Feb 2013, 12:06 pm
J&J Ethicon Surgical Mesh Recall Johnson & Johnson has recalled and removed the Gynecare Prolift Pelvic Floor Repair System, Gynecare Prolift+M Pelvic Floor Repair System, Gynecare Prosima Pelvic Floor Repair System and Gynecare TVT Secure System from the market in June 2012. [read post]
16 Jun 2010, 9:55 pm by Law Office of D. Hardison Wood
McNeil Consumer Healthcare, the Johnson & Johnson unit, said that it was recalling four lots of certain Benadryl allergy tablets and one lot of Extra Strength Tylenol gel pills. [read post]
6 Nov 2013, 6:34 am
More than three years after removing their defective ASR metal-on-metal artificial hip implants from the market, Johnson & Johnson and its subsidiary, DePuy Orthopaedics, are currently in talks to begin settlement negotiations. [read post]
29 Jul 2016, 10:11 am by Laura Davis, AFPD, FDSET
Embry, Judge Sutton notes the differing opinions on whether Johnson v. [read post]
15 Jul 2021, 9:58 am by Whittel & Melton, LLC
Johnson & Johnson confirmed yesterday that they are recalling five sunscreen products after samples of these products were found to contain small amounts of benzene, which is a chemical that has been linked to cancer with repeated use. [read post]
10 Feb 2013, 12:35 pm
Johnson and Johnson Denies Defective Hip Allegations J&J, denies it designed the ASR defectively or that it contributed to the plaintiff's health problems. [read post]
9 Jan 2024, 4:54 pm by Levin Papantonio
Johnson & Johnson (J&J) and representatives for more than 40 states attorneys general are thrashing out terms for an agreement that would settle states’ talc-based baby powder claims, Bloomberg Law reported Monday.Forty-two states have launched a joint investigation into J&J’s marketing practices—specifically, the company’s alleged failure to warn about possible health risks linked to use of talc… [read post]
27 Mar 2012, 12:58 pm by eithurburn@getnicklaw.com
Read the entire articles, “Trial set for Ark. suit over anti-psychotic drugs"; “Texas, Johnson & Johnson heading back to court"; “J&J Duped Arkansas Doctors Over Risperdal, Lawyer Tells Jury"; “J&J tried, failed to squeeze whistle blower in Texas Medicaid case" [read post]
12 Sep 2012, 6:08 pm
California -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. was vindicated Tuesday in its efforts to prevent Lupin Pharmaceuticals Inc. from making and marketing a generic version of J&J's popular birth control drug Ortho Tri-Cyclen Lo, as a New Jersey federal judge ruled that the underlying patent is valid. [read post]
26 Mar 2016, 7:15 am by Associates and Bruce L. Scheiner
Johnson & Johnson, along with its subsidiary DePuy, recently lost a $500 million lawsuit in a consolidated case of five Texas patients who suffered serious injury as a result of defective hip implants. [read post]
12 Oct 2017, 2:02 pm by Bloomberg
Johnson & Johnson said a $417 million verdict in a talc powder cancer case should be thrown out because three jurors were excluded by fellow panelists from the decision-making process. [read post]
29 Aug 2008, 5:48 am
Delaware has invalidated a patent by Johnson & Johnson related to Razadyne, a drug used to treat dementia related to Alzheimer's disease.The basis was lack of enablement. [read post]
21 May 2020, 2:44 pm by Edward Smith
J&J Says Low Demand and COVID-19 Reasons for Discontinuing Sales of Baby Powder Johnson & Johnson announced its decision in May 2020 to permanently stop selling its talc-based baby powder product in the United States and Canada. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
Allegations Include Off-label Marketing and Kickbacks to Doctors and Pharmacists\Global health care giant Johnson & Johnson (J&J) and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians… [read post]
22 Mar 2012, 2:11 pm by info@thomasjhenrylaw.com
   J&J Marketed Mesh Without Approval for 3 Years According to Bloomberg news, Johnson & Johnson first introduced the unapproved device, Gynecare Prolift, in March of 2005, marketing it as an “innovated and effective surgical option for weakened pelvic muscles. [read post]
7 Aug 2012, 9:59 pm by Linda Moss
On Monday Pfizer Inc. and Johnson & Johnson announced that they were shelving late-stage clinical trials of a drug, bapineuzumab, that many had believed would be the first to be approved by federal regulators to slow Alzheimer’s. http://www.pfizer.com/news/press_releases/pfizer_press_release.jsp? [read post]